KACUF
Kairous Acquisition Corp. Limited does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on opportunities in Asia, excluding China in growing technology companies. The company was incorporated in 2021 and is based in … Read more
KACUF (KACUF) - Net Assets
Latest net assets as of March 2025: $3.51 Million USD
Based on the latest financial reports, KACUF (KACUF) has net assets worth $3.51 Million USD as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($10.60 Million) and total liabilities ($7.09 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.51 Million |
| % of Total Assets | 33.12% |
| Annual Growth Rate | 719.03% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 193287.96 |
KACUF - Net Assets Trend (2021–2024)
This chart illustrates how KACUF's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for KACUF (2021–2024)
The table below shows the annual net assets of KACUF from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | $10.29 Million | -45.29% |
| 2023-06-30 | $18.80 Million | -75.48% |
| 2022-06-30 | $76.66 Million | +409965.29% |
| 2021-06-30 | $18.70K | -- |
Equity Component Analysis
This analysis shows how different components contribute to KACUF's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 585976700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $16.15 Million | 157.03% |
| Total Equity | $10.29 Million | 100.00% |
KACUF Competitors by Market Cap
The table below lists competitors of KACUF ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CCSB Financial Corp
PINK:CCFC
|
$6.40 Million |
|
Memphasys Ltd
AU:MEM
|
$6.40 Million |
|
Cimbeton Hazirbeton ve Prefabrik Yapi Elemanlari Sanayi ve Ticaret AS
IS:CMBTN
|
$6.40 Million |
|
Stockwik Forvaltning AB
ST:STWK
|
$6.40 Million |
|
Radiant Utama Interinsco Tbk
JK:RUIS
|
$6.39 Million |
|
Peoplelogy Berhad
KLSE:0356
|
$6.39 Million |
|
Vaswani Industries Limited
NSE:VASWANI
|
$6.39 Million |
|
XMReality AB (publ)
PINK:XMMRF
|
$6.39 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in KACUF's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 18,800,770 to 10,286,271, a change of -8,514,499 (-45.3%).
- Net income of 107,203 contributed positively to equity growth.
- Share repurchases of 8,621,702 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $107.20K | +1.04% |
| Share Repurchases | $8.62 Million | -83.82% |
| Total Change | $- | -45.29% |
Book Value vs Market Value Analysis
This analysis compares KACUF's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.05x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 6268.47x to 4.05x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-06-30 | $0.00 | $11.32 | x |
| 2022-06-30 | $7.56 | $11.32 | x |
| 2023-06-30 | $4.24 | $11.32 | x |
| 2024-06-30 | $2.79 | $11.32 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently KACUF utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.04%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.58x
- Recent ROE (1.04%) is below the historical average (1.11%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | -0.11% | 0.00% | 0.00x | 1.04x | $-7.75 Million |
| 2023 | 2.40% | 0.00% | 0.00x | 1.22x | $-1.43 Million |
| 2024 | 1.04% | 0.00% | 0.00x | 1.58x | $-921.42K |
Industry Comparison
This section compares KACUF's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| KACUF (KACUF) | $3.51 Million | -0.11% | 2.02x | $6.39 Million |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |